ARDM


Also found in: Wikipedia.
AcronymDefinition
ARDMMedium Auxiliary Repair Dry Dock (Non Self-Propelled)
ARDMApostolic Roundtable of Deliverance Ministers (est. 2000)
ARDMArgon Dark Matter (particle physics experiment)
ARDMAge Related Degradation Mechanism
References in periodicals archive ?
Badertscher, F Bay, The ArDM Collaboration et al., "Status of the ArDM experiment: first results from gaseous Argon operation in deep underground environment," http://arxiv.org/abs/1307.0117.
Tickers featured: ADRX, AHP, AMGN, ANPI, ARDM, AZN, BMY, BSX, BVF, DD, DNA, ELN, FRX, GDT, GSK, IMCL, IMNX, IP, JNJ, KG, LLY, MDT, MEDI, MRK, NVO, NVS, OSIP, PFE, PHA, SEPR, SGP, XOMA.
(NASDAQ: ARDM) has been granted filing with priority review by the The US Food and Drug Administration for its new drug application (NDA) for Linhaliq for the treatment of non-cystic fibrosis bronchiectasis (NCFBE) in patients with chronic infections with Pseudomonas aeruginosa (P.
Tickers featured: ABGX, ALKS, ALT, ALXN, AMGN, ARDM, CATG, CORR, CRGN, DNA, GERN, HGSI, IDPH, IMCL, IMNX, INHL, MDCO, MEDI, MEDX, MLNM, MOGN, PDLI, QLTI, REGN, SHPGY, STEM, VRTX, ZGEN.
(NASDAQ: ARDM) a Small Business Initiative Research (SBIR) grant to investigate the treatment of two pulmonary non-tuberculous mycobacteria infections, Mycobacterium avium and Mycobacterium abscessus, with Aradigm's inhaled liposomal ciprofloxacin products Linhaliq and Lipoquin, the company said.
(NAY610) RICHARD THOMPSON - ARADIGM CORPORATION (ARDM).
Tickers featured: ADRX, ALKS, ARDM, ATRX, BJCT, BVF, CHIR, CIMA, COB, ELN, EMIS, ENDP, ENZN, FRX, GSK, INHL, JNJ, KVA, MATX, NOVN, NSTK, NVAX, NVS, PFE, PPCO, SKYE, WPI.
Tickers featured: AGN, ALKS, ARDM, BRL, CIMA, ELN, FRX, ICOS, INHL, IVX, KG, KOSP, MRX, MYL, SCRI, TEVA.
Tickers featured: ARDM, CIMA, ELN, ENDP, INHL, JNJ, NOVN, PPCO, WPI.
(MAJ217) RICHARD THOMPSON - ARADIGM CORPORATION (ARDM).
(KAZ611) RICHARD THOMPSON, CEO of ARADIGM CORPORATION (ARDM), describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward.